Regulatory Approval

The Three-Part Puzzle Holding Back Phage Therapy

Phage therapy, a promising alternative to antibiotics, is hindered by three interconnected challenges: regulatory approval, clinical application complexities, and scalable manufacturing. Addressing these hurdles in a coordinated manner is crucial for its mainstream adoption.